title: Naturally occurring mutations within 39 amino acids in the envelope glycoprotein of maedi-visna virus alter the neutralization phenotype.
abstract: Infectious molecular clones have been isolated from two maedi-visna virus (MVV) strains, one of which (KV1772kv72/67) is an antigenic escape mutant of the other (LV1-1KS1). To map the type-specific neutralization epitope, we constructed viruses containing chimeric envelope genes by using KV1772kv72/67 as a backbone and replacing various parts of the envelope gene with equivalent sequences from LV1-1KS1. The neutralization phenotype was found to map to a region in the envelope gene containing two deletions and four amino acid changes within 39 amino acids (positions 559 to 597 of Env). Serum obtained from a lamb infected with a chimeric virus, VR1, containing only the 39 amino acids from LV1-1KS1 in the KV1772kv72/67 backbone neutralized LV1-1KS1 but not KV1772kv72/67. The region in the envelope gene that we had thus shown to be involved in escape from neutralization was cloned into pGEX-3X expression vectors, and the resulting fusion peptides from both molecular clones were tested in immunoblots for reactivity with the KV1772kv72/67 and VR1 type-specific antisera. The type-specific KV1772kv72/67 antiserum reacted only with the fusion peptide from KV1772kv72/67 and not with that from LV1-1KS1, and the type-specific VR1 antiserum reacted only with the fusion peptide from LV1-1KS1 and not with that from KV1772kv72/67. Pepscan analysis showed that the region contained two linear epitopes, one of which was specific to each of the molecularly cloned viruses. This linear epitope was not bound by all type-specific neutralizing antisera, however, which indicates that it is not by itself the neutralization epitope but may be a part of it. These findings show that mutations within amino acids 559 to 597 in the envelope gene of MVV virus result in escape from neutralization. Furthermore, the region contains one or more parts of a discontinuous neutralization epitope.
authors.affiliation: Institute for Experimental Pathology, University of Iceland, Keldur, Iceland.
authors.forename: R
authors.initials: R
authors.lastname: Skraban
authors.forename: S
authors.initials: S
authors.lastname: Matthíasdóttir
authors.forename: S
authors.initials: S
authors.lastname: Torsteinsdóttir
authors.forename: G
authors.initials: G
authors.lastname: Agnarsdóttir
authors.forename: B
authors.initials: B
authors.lastname: Gudmundsson
authors.forename: G
authors.initials: G
authors.lastname: Georgsson
authors.forename: R H
authors.initials: RH
authors.lastname: Meloen
authors.forename: O S
authors.initials: OS
authors.lastname: Andrésson
authors.forename: K A
authors.initials: KA
authors.lastname: Staskus
authors.forename: H
authors.initials: H
authors.lastname: Thormar
authors.forename: V
authors.initials: V
authors.lastname: Andrésdóttir
mesh_terms: D000595:Amino Acid Sequence; D000596:Amino Acids / Q000235:genetics; D000818:Animals; D008969:Molecular Sequence Data; D010641:Phenotype; D017354:Point Mutation; D016415:Sequence Alignment; D014759:Viral Envelope Proteins / Q000235:genetics*; D014790:Visna-maedi virus / Q000145:classification / Q000235:genetics* / Q000302:isolation & purification
chemical_list: D000596:Amino Acids; D014759:Viral Envelope Proteins